Latest News - Bausch+Lomb

Tuesday, March 21, 2017 | Glaucoma, Bausch+Lomb, Nicox

Bausch + Lomb and Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod

Bausch + Lomb and Nicox announced that the FDA has set a PDUFA date of August 24, 2017 for its decision on the new drug application for latanoprostene bunod ophthalmic solution, 0.024%. Latanoprostene…

Read the full story

Tuesday, March 07, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb UK/I Launches Digital Hub

Bausch + Lomb announced the launch of their enhanced digital hub Bausch.co.uk, a destination for patients and health care professionals to access the latest information on eye concerns and associated …

Read the full story

Thursday, March 02, 2017 | Conferences, Bausch+Lomb

Bausch + Lomb Educates Over 200 Eye Care Professionals During B+Lieve Symposium in San Francisco

Bausch + Lomb continued its educational and training initiative for eye care professionals with the year’s first B+Lieve symposium in San Francisco from February 27-28, 2017. During the event, m…

Read the full story

Wednesday, March 01, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Biotrue ONEday for Astigmatism Contact Lenses

Bausch + Lomb announced the introduction of Biotrue ONEday for Astigmatism daily disposable contact lenses. Approximately 73.2 million people in the U.S. are astigmatic, but only 8.8 million people ar…

Read the full story

Monday, February 27, 2017 | Glaucoma, Bausch+Lomb, Nicox

Bausch + Lomb And Nicox Resubmit FDA New Drug Application For Glaucoma Candidate Latanoprostene Bunod

Bausch + Lomb and Nicox announced the resubmission of a new drug application (NDA) to the FDA seeking approval for latanoprostene bunod ophthalmic solution, 0.024%. Latanoprostene bunod is an IOP-lowe…

Read the full story

Monday, February 13, 2017 | Earnings & Financials, Bausch+Lomb

Bausch + Lomb Ends Unilateral Pricing Policy

Bausch + Lomb became the latest contact lens company to move away from its Unilateral Pricing Policy (UPP) with the announcement late Friday that a “competitive imbalance” had forced the c…

Read the full story

Thursday, February 02, 2017 | Partnerships, Bausch+Lomb, Prevent Blindness

Bausch + Lomb and Prevent Blindness Urge Americans to Fight for Their Sight

Bausch + Lomb is partnering with Prevent Blindness for the second year in a row to urge patients to join the fight for their sight during age-related macular degeneration (AMD) awareness month. This y…

Read the full story

Thursday, January 26, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Specialty Vision Products Introduces ScleralFil Solution for Scleral Lens Insertion

Bausch + Lomb announced the launch of ScleralFil sterile buffered solution with no preservatives, which is indicated for inserting and rinsing scleral lenses. ScleraFil contains no preservative or mer…

Read the full story

Wednesday, January 18, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb Introduces Zen RC Scleral Contact Lenses

Bausch + Lomb has introduced the Zen RC Scleral contact lens, offering eye care professionals (ECPs) a lens that is specifically designed to fit normal corneas and features SmartCurve technology, whic…

Read the full story

Tuesday, January 17, 2017 | Corporate Lawsuits, Bausch+Lomb

Bausch + Lomb Successfully Defends Patent Covering PreserVision Eye Vitamins in Case vs. Vitamin Health Inc.

Bausch + Lomb announced it has resolved its patent infringement lawsuit vs. Vitamin Health, filed in September 2013 in the U.S. District Court for the Western District of New York. Among other claims,…

Read the full story

Thursday, January 12, 2017 | Product Releases, Bausch+Lomb

Bausch + Lomb ULTRA for Presbyopia Contact Lenses Parameters Expanded

Bausch + Lomb announced that Bausch + Lomb ULTRA for Presbyopia contact lenses are now available in an expanded parameter range. Since the contact lenses first launched in February 2016, Bausch + Lomb…

Read the full story

Wednesday, December 21, 2016 | Miscellaneous, Bausch+Lomb

Bausch + Lomb Shares New Letter to US Ophthalmologists

In a new letter to US ophthalmologists, Bausch + Lomb wrote: Dear Eye Care Professional: 2016 has been an exceptional year for Bausch + Lomb and the growth of our business as we have introduced …

Read the full story

Tuesday, December 13, 2016 | Product Releases, Bausch+Lomb

Bausch + Lomb Specialty Vision Products Launches New 28 Lens Zenlens Dx Set

Bausch + Lomb announced that it has launched the Zenlens diagnostic lenses in a new 28 lens set format. Adding to the classic Zenlens 24 lens Dx format, which features six lenses in two diameters (16 …

Read the full story

Wednesday, November 09, 2016 | Miscellaneous, Bausch+Lomb, Nicox , Valeant

Nicox Provides Update on Latanoprostene Bunod and AC-170

Nicox SA provided an update on the regulatory status of its key projects, latanoprostene bunod and AC-170. Valeant Pharmaceuticals has stated that Nicox's licensee for latanoprostene bunod, Bau…

Read the full story

Tuesday, November 08, 2016 | Acquisitions/Mergers, Earnings & Financials, Bausch+Lomb, Paragon BioTeck, Valeant

Valeant Agrees to Sell Paragon to Settle U.S. Antitrust Charges

Valeant Pharmaceuticals, which owns eye care products maker Bausch & Lomb, has agreed to sell Paragon Holdings to settle allegations that its acquisition of the smaller company was illegal under a…

Read the full story
Load More